WFM
ZBH icon

Wilmington Funds Management’s Zimmer Biomet ZBH Stock Holding History

Wilmington Funds Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$240K Sell
2,379
-2,266
-49% -$221K 0.02% 610
2014
Q1 		$427K Hold
4,645
– – 0.05% 408
2013
Q4 		$420K Hold
4,645
– – 0.04% 449
2013
Q3 		$370K Buy
4,645
+1,545
+50% +$122K 0.04% 481
2013
Q2 		$226K Buy
+3,100
New +$232K 0.02% 615

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Wilmington Funds Management's ZBH Position: Q2 2014 in Review

Wilmington Funds Management reduced its Zimmer Biomet (ZBH) stake by 49% in Q2 2014, selling an estimated $221K and leaving 2,379 shares worth $240K. The position accounts for 0.02% of the portfolio, ranked #610.

Wilmington Funds Management first reported a position in ZBH in Q2 2013 and has held it in 5 quarters since. The position peaked at $427K in Q1 2014. 707 funds tracked by Wall St. Rank hold ZBH as of Q2 2014.

  • Wilmington Funds Management held 2,379 shares of Zimmer Biomet worth $240K as of Q2 2014.
  • Wilmington Funds Management sold 2,266 Zimmer Biomet shares in Q2 2014, an estimated $221K.
  • Zimmer Biomet made up 0.02% of Wilmington Funds Management's portfolio in Q2 2014, its #610 holding.
  • Wilmington Funds Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Funds Management's Zimmer Biomet position peaked at $427K in Q1 2014.
  • 707 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.